¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Muscle wasting and atrophy, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • pterygoid muscle
    ³¯°³±Ù, ÀÍ»ó±Ù
  • pterygopharyngeus muscle
    ³¯°³ÀεαÙ, À͵¹ÀεαÙ
  • pubococcygeus muscle
    µÎµ¢²¿¸®±Ù, Ä¡°ñ¹Ì°ñ±Ù
  • puborectalis muscle
    µÎµ¢°ðâÀÚ±Ù, Ä¡°ñÁ÷Àå±Ù
  • pubovaginalis muscle
    µÎµ¢Áú±Ù, Ä¡°ñÁú±Ù
  • pyramidalis muscle
    ¹è¼¼¸ð±Ù, Ãßü±Ù
  • pectinate muscle
    ºø»ì±Ù, Áñ»ó±Ù
  • pectoralis major muscle
    Å«°¡½¿±Ù, ´ëÈä±Ù
  • pectoralis minor muscle
    ÀÛÀº°¡½¿±Ù, ¼ÒÈä±Ù
  • palatoglossus muscle
    ÀÔõÀåÇô±Ù, ±¸°³¼³±Ù
  • palatopharyngeus muscle
    ÀÔõÀåÀεαÙ, ±¸°³ÀεαÙ
  • peroneus brevis muscle
    ªÀºÁ¾¾Æ¸®±Ù, ´Üºñ°ñ±Ù
  • peroneus longus muscle
    ±äÁ¾¾Æ¸®±Ù, Àåºñ°ñ±Ù
  • peroneus tertius muscle
    ¼Â°Á¾¾Æ¸®±Ù, Á¦»ïºñ°ñ±Ù
  • palmaris brevis muscle
    ªÀº¼Õ¹Ù´Ú±Ù, ´Ü¼öÀå±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • mylohyoid muscle
    Åθñ»Ô±Ù
  • nasalis muscle
    ÄÚ±Ù
  • nonstriated muscle
    ¹Î¹«´Ì±ÙÀ°, ÆòȰ±Ù
  • oblique muscle
    ºø±Ù
  • oblique arytenoid muscle
    ºø¸ð»Ô±Ù
  • occipitofrontal muscle
    µÚÅë¼öÀ̸¶±Ù
  • ocular muscle
    ¹Ù±ù´«±ÙÀ°, ¾È±¸±ÙÀ°
  • omohyoid muscle
    ¾î±ú¸ñ»Ô±Ù
  • opponens pollicis muscle
    ¾öÁö¸Â¼¶±Ù
  • orbicular muscle
    µÑ·¹±Ù
  • orbicularis oculi muscle
    ´«µÑ·¹±Ù
  • orbicularis oris muscle
    ÀԵѷ¹±Ù
  • palatoglossus muscle
    ÀÔõÀåÇô±Ù
  • palatopharyngeus muscle
    ÀÔõÀåÀεαÙ
  • palmaris brevis muscle
    ªÀº¼Õ¹Ù´Ú±Ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • posterior tibial muscle ³ª musculus tibialis p.
    µÚ°æ°ñ±Ù, Èİæ°ñ±Ù( ý­ÌëÍéÐÉ).
  • preseptal muscle
    ÀüÁ߰ݱÙ
  • prevertebral muscle
    ÃßÀü±Ù
  • procerus muscle
    ´«»ì±Ù
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • proximal muscle
    ±ÙÀ§±Ù(ÐÎêÈÐÉ).
  • psoas major muscle
    Å«Ç㸮±Ù, ´ë¿ä±Ù.
  • psoas major muscle
    ´ë¿ä±Ù
  • psoas minor muscle
    ¼Ò¿ä±Ù
  • psoas muscle
    ¿ä±Ù
  • pterygoid muscle
    ³¯°³±ÙÀ°, À͵¹±Ù(ìÏÔÍÐÉ).
  • pterygoid muscle
    À͵¹±Ù
  • pterygoid muscle lateral
    ¿ÜÃø³¯°³±Ù, ¿ÜÀ͵¹±Ù(èâìÏÔÍÐÉ).
  • pterygoid muscle medial
    ³»Ãø³¯°³±Ù, ³»À͵¹±Ù(Ò®ìÏÔÍÐÉ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • optic atrophy
    ½Ã½Å°æÀ§Ãà(ãÊãêÌèê×õê).
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà(¡­ê×õê).
  • perifollicular macular atrophy
    ¸ð³¶ ÁÖÀ§ ¹Ý»ó À§Ãà
  • peripapillary chorioretinal atrophy
    À¯µÎÁÖÀ§¸Æ¶ô¸Á¸·À§Ãà
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
  • pigmentary atrophy
    »ö¼Ò¼º À§Ãà(ßäáÈàõ ê×õê)
  • postinflammatory optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • postneuritic optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • pressure atrophy
    ¾Ð¹ÚÀ§Ãà(äâÚÞê×õê).
  • primary optic atrophy
    ¿ø¹ß½Ã½Å°æÀ§Ãà(ê«Û¡ãÊãêÌèê×õê).
  • primary optic atrophy
    ¿ø¹ß(¼º) ½Ã½Å°æÀ§Ãà(ê«Û¡(àõ) ãÊãêÌèê×õê)
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõø¸äÔØüê×õê ).
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõ ø¸äÔØüê×õê )
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
AMC academic medical center; acetylmethyl carbinol; Animal Medical Center; antibody-mediated cytotoxicit...
AMR acoustic muscle reflex; activity metabolic rate; acute mitral stenosis; alopecia-mental retardation ...
ASMA antismooth muscle antibody
ASMC arterial smooth muscle cell
ASMD anterior segment mesenchymal dysgenesis; atonic sclerotic muscle dystrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
ML Muscle length
MM Muscle mass
MSA Muscle nerve sympathetic activity
MR Muscle relaxants
MuSK Muscle specific kinase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • masticatory muscle silent
    ÀúÀÛ±ÙÀÇ ÈÞÁö±â
  • motor nerve fiber of skeletal muscle
    °ñ°Ý±ÙÀÇ ¿îµ¿ ½Å°æ ´º·±
  • muscle activity
    ±Ù Ȱ¼º
  • muscle biopsy
    ±Ù »ý°Ë
    °ñ°Ý±ÙÀÇ ÀϺθ¦ ÀýÁ¦ÇÏ¿© Á¶Á÷ÇÐÀûÀ¸·Î °Ë»öÇÏ´Â ¹æ¹ýÀ¸·Î¼­, ½Å°æ±Ù ÁúȯÀÇ Áø´Ü, º´Å ÆÄ¾ÇÀÇ ÇÑ ÀÚ·á·Î »ï´Â´Ù. ¶Ç Çʿ信 µû¶ó¼­ ±Ù Á¶Á÷³» ¹°ÁúÀÇ »ýÈ­ÇÐÀû ºÐ¼®À» ½Ç½ÃÇÑ´Ù. äÃëÇÑ ±ÙÀ°Àº ¼öÃàÇϹǷΠ½ÅÀü±â·Î ´Ã·Á¼­ Æ÷¸£¸»¸° °íÁ¤À» ÇÑ´Ù. Àý°³´Â ±Ù ¼¶À¯ÀÇ ±æÀÌ ¹æÇâÀ¸·Î ÀÚ¸£´Â Á¾´Ü¸é°ú Áö°¢À¸·Î ÀÚ¸£´Â Ⱦ´Ü¸é°úÀÇ 2¹æÇâÀ¸·Î Àß¶ó³» Ç¥º»À» ¸¸µé¾î¼­ °Ë»öÇÑ´Ù. ±Ù »ý°Ë¿¡ ÀÇÇØ ±ÙÀÌ¿µ¾çÁõ, ÇǺΠ±Ù¿° µî ±ÙÀÇ º¯¼ºÀ̳ª ¿°ÁõÀÇ »óŸ¦ ¾Ë ¼ö°¡ ÀÖ´Ù.
  • muscle cell
    ±Ù ¼¼Æ÷
    ´Éµ¿ÀûÀ¸·Î ¼öÃ༺À» º¸ÀÌ´Â µ¿¹°Ã¼³»ÀÇ ¼¼Æ÷. ±ÙÀ° ¼¼Æ÷¶ó°íµµ ÇÑ´Ù. ±Ù Á¶Á÷À» ±¸¼ºÇÏ´Â °æ¿ì °¢°¢ÀÇ ±Ù ¼¼Æ÷´Â ÀϹÝÀûÀ¸·Î ¹æÃß»ó ¶Ç´Â ¼¶À¯»óÀ» ¶í´Ù. ÇØ¸éµ¿¹°Àº ±ÙÁ¶Á÷ÀÌ ¾øÀ¸³ª, ±Ô°¢ ÇØ¸é·ù¿¡¼­´Â üǥÀÇ ÆíÆò»óÇÇ ¼¼Æ÷°¡ ¾ó¸¶°£ ¼öÃ༺À» °¡Áö¸ç, üǥ ƯÈ÷ À¯Ãâ°ø ÁÖº¯¿¡ ¹Ì¿À»çÀÌÆ®¶ó°í ÇÏ´Â ±ä ¹æÃßÇüÀÇ ¼öÃ༺ ¼¼Æ÷°¡ Á¸ÀçÇÑ´Ù. ¶Ç ¼®È¸ ÇØ¸é·ùÀÇ ¼Ò°ø ¼¼Æ÷¿¡µµ ¼öÃ༺ÀÌ ÀÎÁ¤µÈ´Ù. À̵éÀº ¾î¶² Á¾·ùÀÇ ¿ø»ýµ¿¹° ¸ö Àüü¿¡ ³ªÅ¸³ª´Â ¼öÃ༺°ú ´õºÒ¾î ±Ù ¼¼Æ÷°¡ ³ªÅ¸³ª´Â ½ÃÀÛ ÇüÅ·Π°£ÁֵȴÙ. °­À嵿¹°ÀÇ Æú¸³Çü¿¡¼­´Â ¿Ü¹è¿± ¼¼Æ÷ Ãþ ¼Ó¿¡ ÀÖ´Â »óÇÇ ±Ù ¼¼Æ÷¿¡ ÁøÁ¤ÇÑ ±Ù¿ø¼¶À¯°¡ ÀÖ´Ù. À̰ÍÀº °¡Àå ÈçÈ÷ ÀÖ´Â ¿øÁÖ»óÇÇ ¼¼Æ÷, ÁïÁöÁö ¼¼Æ÷ÀÇ ±âÀúºÎ°¡ ¹æÃßÇüÀ¸·Î ´Ã¾î³ª¼­ ±× ºÎºÐ¿¡ ÇÑÇØ¼­ ±Ù¿ø¼¶À¯°¡ Á¸ÀçÇÏ´Â °ÍÀ¸·Î, üǥÀÇ »óÇÇ ¼¼Æ÷¿¡¼­ ±Ù¼¼Æ÷·Î ºÐÈ­ÇÏ´Â µµÁßÀÇ °ÍÀÌ´Ù. ÇØÆÄ¸® Çü¿¡¼­´Â ¹æÃßÇü ±Ù ¼¼Æ÷°¡ ¿Ï¼ºµÈ´Ù. ÆíÇüµ¿¹° À̻󿡼­´Â ÇDZÙÃþ, ±â°ü±Ù µî ºÐÈ­°¡ ÇöÀúÇÏ´Ù.
  • muscle compartment syndrome
    ±Ù ±¸¿ª ÁõÈıº
    ±Ù ±¸¿ª ³»ÀÇ »ê¼Ò ºÎÁ·À¸·Î ÀÎÇÏ¿© ±ÙÀ°¿¡ ÅëÁõÀ̳ª »»»»ÇÔÀÌ ¹ß»ýÇÑ °Í.
  • muscle conditioning exercise
    ±Ù Á¶°ÇÈ­ ¿îµ¿
  • muscle contraction headache
    ±Ù ±äÀ强 µÎÅë, ±Ù ¼öÃ༺ µÎÅë
    °¡Àå ºóµµ°¡ ¸¹Àº µÎºÎ³ª °æºÎ ±ÙÀ°ÀÇ ¸¸¼ºÀû ¼öÃà¿¡ ±âÀÎÇÑ´Ù. µÐÇϰí ÁËÀÌ´Â °Í °°Àº Áö¼ÓÀûÀÎ ¾Ð¹Ú¼ºÀÇ ÅëÁõÀÌ°í ¼öÀÏ ³»Áö ¼ö°³¿ù °è¼ÓµÈ´Ù. ÀÏ»ó »ýȰÀÇ ½ºÆ®·¹½º¿¡ ´ëÇÑ °³Ã¼ ¹ÝÀÀÀ¸·Î¼­ »ý±â°í ¿ÀÈĺÎÅÍ Àú³á¿¡ ´õ¿í ½ÉÇØÁø´Ù. ±äÀ强 µÎÅëÀ¸·Î ÀÏÄþîÁö´Â °ÍÀº ´ëºÎºÐÀÌ À̰Ϳ¡ Æ÷ÇԵȴÙ. °¡º­¿î ¿ì¿ï °æÇâÀ» º¸ÀÌ´Â °æ¿ì°¡ ¸¹´Ù. ¸À»çÁö, ¿­ ÁÖ¸Ó´Ï, ±Ù ÀÌ¿ÏÁ¦, Ç׿ì¿ïÁ¦, ¹ÙÀÌ¿ÀÇǵå¹é ±Ù À̿Ϲý µîÀÌ È¿°ú°¡ ÀÖ´Ù.
  • muscle corpuscle
    ±Ù ¼Òü
  • muscle disorder
    ±ÙÀ° Àå¾Ö, ±Ù Àå¾Ö
  • muscle effect
    ±ÙÀ° È¿°ú
  • muscle fatigue
    ±ÙÀ° ÇÇ·Î, ±Ù ÇÇ·Î
    ½Å°æ±Ù Ç¥º»ÀÇ ½Å°æÀ» µÇÇ®ÀÌÇØ¼­ Àü±â ÀÚ±ØÇÏ°í ±ÙÀ» ½¯»õ¾øÀÌ ¼öÃà½ÃŰ¸é °á±¹¿¡´Â ±ÙÀÌ ¼öÃàÇÏÁö ¾Ê°Ô µÈ´Ù. À̶§ ±Ù ±× ÀÚü¿¡ Àü·ù¸¦ ÁýÁß½ÃŰ°í ±ÙÀ» Á÷Á¢ ÀÚ±ØÇÏ¸é ±ÙÀº ´Ù½Ã ¼öÃàÇϴµ¥ ÀÌ ¹æ¹ýÀ¸·Îµµ ¼öÃàÀ» °è¼ÓÇÒ ¼ö°¡ ¾ø°Ô µÈ´Ù. ÀÌ¿Í °°Àº »óŸ¦ ±Ù ÇǷζó°í ÇÑ´Ù.
  • muscle fibril
    ±Ù¿ø ¼¶À¯
    µ¿ÀǾî=myofibril.
  • muscle force
    ±Ù·Â
    µ¿ÀǾî=muscle strength.
  • muscle graft
    ±ÙÀ° À̽Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
combined heat and power An older term for what is now generally called cogeneration. The term is currently used in Europe and other foreign countries.
(05 Dec 1998)
wheal-and-erythema reaction The characteristic immediate reaction observed in the skin test; within 10 to 15 minutes after injection of antigen (allergen), an irregular, blanched, elevated wheal appears, surrounded by an area of erythema (flare).
Synonym: wheal-and-flare reaction.
(05 Mar 2000)
wheal-and-flare reaction The characteristic immediate reaction observed in the skin test; within 10 to 15 minutes after injection of antigen (allergen), an irregular, blanched, elevated wheal appears, surrounded by an area of erythema (flare).
Synonym: wheal-and-flare reaction.
(05 Mar 2000)
commission on professional and hospital activities The non-profit, non-governmental organization which collects, processes, and distributes data on hospital use. Two programs of the commission are the professional activity study and the medical audit program.
(12 Dec 1998)
plant families and groups Groupings that include specific plants within larger families or divisions.
(12 Dec 1998)
plaque and tartar cause (12 Dec 1998)
play and playthings Spontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc.
(12 Dec 1998)
confluent and reticulate papillomatosis Discrete and confluent gray-brown papules of the anterior and posterior mid-chest, spreading gradually; Malassezia furfur has been found in the keratin layer.
Synonym: Gougerot-Carteaud syndrome.
(05 Mar 2000)
wounds and injuries Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.
(12 Dec 1998)
conor and bruch's disease African tick typhus, one of the tick-borne rickettsial diseases of the eastern hemisphere, similar to Rocky Mountain spotted fever, but less severe, with fever, a small ulcer (tache noire) at the site of the tick bite, swollen glands nearby (satellite lymphadenopathy), and a red raised (maculopapular) rash. Also called boutonneuse and fi
constitution and bylaws The fundamental principles and laws adopted by an organization for the regulation and governing of its affairs.
(12 Dec 1998)
musculoskeletal, neural, and ocular physiology Activities and functions of the musculoskeletal system, the nervous system, and the eye and their parts.
(12 Dec 1998)
poikiloderma atrophicans and cataract The rothmund-thomson syndrome, a genetic disorder with numerous features affecting skin (premature aging, excess pigmentation, dilated blood vessels),eyes ( uvenile cataract), nose (saddle nose), teeth (maldeveloped), skeletal system (congenital bone defects) hair (abnormal), gonads (underdevelopment) limbs (soft tissue contractures), growth (short stature). Blood (anaemia) and a tendency to develop a type of bone cancer (osteogenic sarcoma). The rts gene is on chromosome 8. The syndrome is recessive so to be affected with rts a child has to have two rts genes, one from each parent.
(12 Dec 1998)
coroners and medical examiners Physicians appointed to investigate all cases of sudden or violent death.
(12 Dec 1998)
myasthenia gravis and thymoma <radiology> Of patients with MG 15% have thymoma, of patients with thymoma 50% have MG
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á